Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Autor: Alva AS; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Mangat PK; American Society of Clinical Oncology, Alexandria, VA., Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA., Halabi S; Duke University Medical Center, Durham, NC., Hansra D; Cancer Treatment Centers of America, Atlanta, GA., Calfa CJ; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Khalil MF; Lehigh Valley Cancer Institute, Allentown, PA., Ahn ER; Cancer Treatment Centers of America, Chicago, IL., Cannon TL; Inova Schar Cancer Institute, Fairfax, VA., Crilley P; Cancer Treatment Centers of America, Philadelphia, PA., Fisher JG; Levine Cancer Institute, Atrium Health, Charlotte, NC., Haslem DS; Intermountain Logan Cancer Clinic, Logan, UT., Shrestha S; Cancer Treatment Centers of America, Tulsa, OK., Antonelli KR; American Society of Clinical Oncology, Alexandria, VA., Butler NL; American Society of Clinical Oncology, Alexandria, VA., Warren SL; American Society of Clinical Oncology, Alexandria, VA., Rygiel AL; American Society of Clinical Oncology, Alexandria, VA., Ranasinghe S; American Society of Clinical Oncology, Alexandria, VA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Aug 01; Vol. 39 (22), pp. 2443-2451. Date of Electronic Publication: 2021 Apr 12.

Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Autor: Fisher JG; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Tait D; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Garrett-Mayer E; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA., Halabi S; Duke University Medical Center, Durham, NC, USA., Mangat PK; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA. TAPURPublications@asco.org., Schink JC; Cancer Treatment Centers of America, Chicago, IL, USA., Alvarez RH; Cancer Treatment Centers of America, Atlanta, GA, USA., Veljovich D; Swedish Cancer Institute, Seattle, WA, USA., Cannon TL; Inova Schar Cancer Institute, Fairfax, VA, USA., Crilley PA; Cancer Treatment Centers of America, Philadelphia, PA, USA., Pollock T; Cancer Treatment Centers of America, Tulsa, OK, USA., Calfa CJ; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Al Baghdadi T; Michigan Cancer Research Consortium, Ypsilanti, MI, USA., Thota R; Intermountain Precision Genomics Cancer Clinic, Salt Lake City, UT, USA., Fleming N; The University of Texas MD Anderson Cancer Center, Sugarland, TX, USA., Cotta JA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Rygiel AL; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA., Warren SL; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA., Schilsky RL; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA.

Publikováno v: Targeted oncology [Target Oncol] 2020 Dec; Vol. 15 (6), pp. 733-741.

Palbociclib in Patients With Pancreatic and Biliary Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Autor: Al Baghdadi T; Michigan Cancer Research Consortium, Ypsilanti, MI., Halabi S; Duke University Medical Center, Durham, NC., Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA., Mangat PK; American Society of Clinical Oncology, Alexandria, VA., Ahn ER; Cancer Treatment Centers of America, Chicago, IL., Sahai V; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Alvarez RH; Cancer Treatment Centers of America, Atlanta, GA., Kim ES; Levine Cancer Institute, Atrium Health, Charlotte, NC., Yost KJ; Cancer Research Consortium of West Michigan, Grand Rapids, MI., Rygiel AL; American Society of Clinical Oncology, Alexandria, VA., Antonelli KR; American Society of Clinical Oncology, Alexandria, VA., Butler NL; American Society of Clinical Oncology, Alexandria, VA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2019 Dec; Vol. 3, pp. 1-8.

Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer.

Autor: Miao, Qian, Zheng, Xinlong, Li, Lifeng, Zheng, Xiaobin, Zhang, Longfeng, Jiang, Kan, Wu, Shiwen, Wang, Haibo, Wu, Biao, Xu, Yiquan, Zhong, Qiaofeng, Zou, Zihua, Zhang, Qiuyu, Yang, Shanshan, Li, Yujing, Lin, Gen

Publikováno v: Journal of Neuro-Oncology; Dec2023, Vol. 165 Issue 3, p517-525, 9p

Targeted genomic analysis of 364 adrenocortical carcinomas.

Autor: Pozdeyev, Nikita, Fishbein, Lauren, Gay, Laurie M., Sokol, Ethan S., Hartmaier, Ryan, Ross, Jeffrey S., Darabi, Sourat, Demeure, Michael J., Kar, Adwitiya, Foust, Lindsey J., Koc, Katrina, Bowles, Daniel W., Leong, Stephen, Wierman, Margaret E., Kiseljak-Vassiliades, Katja

Publikováno v: Endocrine-Related Cancer; Oct2021, Vol. 28 Issue 10, p671-681, 11p